Recruitment

Eingeschlossene Patienten: 23.308 (Stand 03. Februar 2025)
Amgevita® (Adalimumab)244
Benepali® (Etanercept)1247
Cimzia® (Certolizumab)1044
Enbrel® (Etanercept)2877
Erelzi® (Etanercept)581
Flixabi® (Infliximab)10
Hukyndra® (Adalimumab)10
Hulio® (Adalimumab)276
Humira® (Adalimumab)2911
Hyrimoz® (Adalimumab)252
Idacio® (Adalimumab)68
Imraldi® (Adalimumab)237
Inflectra™ (Infliximab)16
Jyseleca® (Filgotinib)163
Kevzara® (Sarilumab)227
Kineret® (Anakinra)89
MabThera® (Rituximab)1459
Nepexto® (Etanercept)96
Olumiant® (Baricitinib)550
Orencia® (Abatacept)994
Remicade® (Infliximab)762
Remsima® (Infliximab)27
Rinvoq® (Upadacitinib)321
Rixathon® (Rituximab)20
RoActemra® (Tocilizumab)1379
Ruxience® (Rituximab)1
Simponi® (Golimumab)476
Truxima® (Rituximab)3
Tyenne® (Tocilizumab)50
Xeljanz® (Tofacitinib)400
Yuflyma® (Adalimumab)50
Zessly® (Infliximab)2
Kontrollen6466